Autonomix Medical Expands U.S. Patent Protection for Neuromodulation
THE WOODLANDS, Texas, Aug. 26, 2026 Autonomix Medical, Inc. has expanded its intellectual property portfolio with the issuance of...
Autonomix Medical
Advertisement
Autonomix Medical Completes GLP Study for FDA Submission
THE WOODLANDS, Texas, August 12, 2026 Autonomix Medical, Inc. announced the successful completion of a Good Laboratory Practice (GLP)...
Autonomix Medical Secures New U.S. Patent for Precision Neuromodulation Platform
THE WOODLANDS, Texas, July 23, 2026 Autonomix Medical, Inc. announced that it has been granted U.S. Patent No. 12,471,776,...
Autonomix Secures Canadian Patent for Neural Sensing
THE WOODLANDS, Texas, July 13, 2026 Autonomix Medical announced the grant of Canadian Patent No. 3,158,197, titled “Endoscopic Sympathectomy...
Autonomix Expands Scientific Validation Strategy
February 25, 2026 – The Woodlands, Texas, USA Autonomix Medical, Inc. has announced the release of a new CEO...
Advertisement
